IPO

Sudarshan Pharma Industries Ltd IPO

BSE SME

Listed On: Mar 22, 2023 at ₹ 73.0

₹ 233600 /3200 Shares
*Min Investment

Check Allotment

09 Mar, 2023

Open Date

14 Mar, 2023

Close Date

17 Mar, 2023

Allotment Date

22 Mar, 2023

Listing Date
Sudarshan Pharma Industries Ltd IPO Issue Details
  • Issue Price ₹71-73 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr)
  • Listing at BSE SME
  • List Price 73.0
  • Listing Date 2023-03-22
  • Lead Manager Gretex Corporate Services Pvt Ltd
  • Registrar KFin Technologies Limited
Sudarshan Pharma Industries Ltd IPO Details
  • Retail Portion N/A
Sudarshan Pharma Industries Ltd IPO Documents
Sudarshan Pharma Industries Ltd IPO Details


Sudarshan Pharma Industries Ltd IPO is an SME IPO, priced at ₹71-73 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform.

The IPO bidding window is open from Mar 9, 2023 to Mar 14, 2023. The allotment is expected to be finalized on Mar 17, 2023, and the tentative listing date is Mar 22, 2023.


The registrar of the IPO is KFin Technologies Limited, and

Read More
Sudarshan Pharma Industries Ltd IPO Subscription Analysis And Details
Retail
1.20x
Total
1.06x
As onQIB / NIIRetailTotal
Shares Offered / Reserved521,600 / 1,908,8003,651,2006,081,600
Day 1 09-03-23 06:00 PM
0.00 / 0.37 x0.46 x0.40 x
Day 2 10-03-23 06:00 PM
0.00 / 0.38 x0.67 x0.52 x
Day 3 13-03-23 06:00 PM
0.00 / 0.58 x0.88 x0.71 x
Day 4 14-03-23 06:00 PM
1.01 / 0.81 x1.20 x1.06 x
Sudarshan Pharma Industries Ltd Valuations
Earnings Per Share (EPS) ₹3.39/-
P/E Ratio N/A
RoNW 17.63%
Net Asset Value (NAV) - Post Issue ₹30.54/-
Sudarshan Pharma Industries Ltd Company Financials
In Lakhs
In Lakh
30-Jun-2231-Mar-2231-Mar-2131-Mar-20
Assets14,703.7413,752.189,926.02N/A
Revenue10,587.7935,755.8919,372.82N/A
Profit After Tax225.37530.37267.12N/A
About Sudarshan Pharma Industries Ltd Company

Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.

The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.

The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.

Read More
Sudarshan Pharma Industries Ltd - Promoter(s)

Mr. Hemal Vasantrai Mehta

Mr. Sachin Vasantrai Mehta

Pre Issue Share Holding : 80.28%

Post Issue Share Holding : %

Sudarshan Pharma Industries Ltd IPO - Issue Objectives
1

Working Capital Requirements

2

General Corporate Purposes.